Stocks / Pharmaceuticals
HROWPharmaceuticals
Harrow, Inc.
$34.071d -1.6%5d -11.6%settled close · 2026-09-14
Mkt cap $1.3B (3/25)β 1.4352w $30–55Shares 37.2MInd. Pharmaceutical PreparationsNasdaq since 2007Emp. 373HQ Nashville, TNharrow.com
Who’s talkingIdea Scout · free
Who’s talking about HROW
No tracked investor commentary on HROW yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 9 Nov 2026
Confirmed date · consensus EPS 0.23. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 10 Aug 2026 | after the close | -0.46 vs -0.18 | +2.3% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where HROW’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 13 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-14 | ||||||
| 2026-08-25 | ||||||
| 2026-08-11 | ||||||
| 2026-08-10 | ||||||
| 2026-06-17 | ||||||
| 2026-05-12 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 | ||||||
| 2026-04-17 | ||||||
| 2026-04-16 | ||||||
| 2026-04-15 | ||||||
| 2026-04-14 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
HROW is in this morning’s Brief.
Get The Brief — $20/mo →